ExploreInterventionMulticomponent quality improvement intervention
Intervention

Multicomponent quality improvement intervention

Also known as: Multicomponent quality improvement intervention (non-physician care coordinator + decision-support EHR) plus usual care, combined across both CARRS Trial arms over median 28 months QI
3 findings 1 paper 4 related entities View in graph →

Related entities

conditions
outcomes
populations
studys

Findings (27)

None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1
None
decline

Overall, only 16.3% (95% CI: 14.6-18.1) of participants with poorly controlled type 2 diabetes at baseline achieved guideline-recommended glycemic control (HbA1c <7%) over the study period, while 34.9

Effect: decline; 16.3%; CI: 95% CI: 14.6, 18.1

Size: 16.3% CI: 95% CI: 14.6, 18.1

Papers (1)